Ams Meditech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-01-2025
- Paid Up Capital ₹ 0.50 M
as on 19-01-2025
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.80 M
as on 19-01-2025
- Revenue -21.40%
(FY 2023)
- Profit -47.44%
(FY 2023)
- Ebitda -44.65%
(FY 2023)
- Net Worth 88.59%
(FY 2023)
- Total Assets 77.31%
(FY 2023)
About Ams Meditech India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.80 M.
Jaheer Mohideen and Thamina serve as directors at the Company.
- CIN/LLPIN
U85100TN2014PTC095378
- Company No.
095378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ams Meditech India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaheer Mohideen  | Managing Director | 11-Mar-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thamina | Director | 04-Nov-2020 | Current |
Financial Performance of Ams Meditech India.
Ams Meditech India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.4% decrease. The company also saw a substantial fall in profitability, with a 47.44% decrease in profit. The company's net worth Soared by an impressive increase of 88.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ams Meditech India?
Unlock access to Ams Meditech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jun 2023 | Hdfc Bank Limited | ₹0.80 M | Open |
How Many Employees Work at Ams Meditech India?
Unlock and access historical data on people associated with Ams Meditech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ams Meditech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ams Meditech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
